India's Pharmaceutical Exports

Country Profile

Egypt

Egypt is a significant market for Indian pharmaceutical exports — $202M in FY 2025–26, with 2.2× growth over the past decade. Medicine Ingredients accounts for 67% of shipments, with vaccines contributing $24.1M. The compound annual growth rate since FY2015 stands at 7.6%.

🇪🇬 $202M · 2.2× growth since FY2015 · 7.6% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$202M
Exports FY2025–26 DGCIS
2.2×
Growth FY2015→2026
7.6%
CAGR FY2015→2026
67%
Medicine Ingredients Share
5
Product Categories Supplied
Egypt is a significant market for Indian pharmaceutical exports — $202M in FY 2025–26, with 2.2× growth over the past decade. Medicine Ingredients accounts for 67% of shipments, with vaccines contributing $24.1M. The compound annual growth rate since FY2015 stands at 7.6%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $135M (67.1%) Medicines $32.8M (16.2%) Vaccines $24.1M (11.9%) Surgical & Hospital Supplies $8.11M (4.0%) Traditional & Herbal $1.41M (0.7%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Egypt in the RBI overseas direct investment dataset (2011–2026).